New law taking time to improve availability of biomaterials to device manufacturers in US
This article was originally published in Clinica
Executive Summary
US medical device manufacturers have seen only a modest improvement in the availability of raw materials since the Biomaterials Access Assurance Act became law in August last year. The legislation was designed to shield biomaterial suppliers from liability for failed implants.